A detailed history of Alpine Bank Wealth Management transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Alpine Bank Wealth Management holds 210 shares of VRTX stock, worth $102,998. This represents 0.02% of its overall portfolio holdings.

Number of Shares
210
Previous 238 11.76%
Holding current value
$102,998
Previous $111 Million 8.02%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025

SELL
$402.49 - $513.76 $11,269 - $14,385
-28 Reduced 11.76%
210 $102 Million
Q3 2024

Nov 12, 2024

BUY
$460.0 - $505.78 $109,480 - $120,375
238 New
238 $111 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $126B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Alpine Bank Wealth Management Portfolio

Follow Alpine Bank Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Bank Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Bank Wealth Management with notifications on news.